Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 33 studies | 49% ± 20% | |
| smooth muscle cell | 22 studies | 27% ± 10% | |
| pericyte | 19 studies | 27% ± 8% | |
| connective tissue cell | 13 studies | 43% ± 17% | |
| myofibroblast cell | 12 studies | 39% ± 17% | |
| basal cell | 10 studies | 29% ± 8% | |
| endothelial cell | 9 studies | 27% ± 6% | |
| epithelial cell | 9 studies | 29% ± 9% | |
| enterocyte | 7 studies | 30% ± 12% | |
| endothelial cell of lymphatic vessel | 6 studies | 24% ± 5% | |
| goblet cell | 6 studies | 31% ± 7% | |
| transit amplifying cell | 5 studies | 29% ± 14% | |
| adventitial cell | 5 studies | 40% ± 17% | |
| endothelial cell of vascular tree | 5 studies | 26% ± 8% | |
| luminal cell of prostate epithelium | 4 studies | 43% ± 10% | |
| intestinal crypt stem cell | 3 studies | 26% ± 8% | |
| glutamatergic neuron | 3 studies | 29% ± 9% | |
| ciliated cell | 3 studies | 24% ± 6% | |
| keratinocyte | 3 studies | 26% ± 8% | |
| secretory cell | 3 studies | 29% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 36086.24 | 245 / 245 | 99% | 314.91 | 499 / 502 |
| intestine | 100% | 20482.81 | 966 / 966 | 98% | 225.97 | 517 / 527 |
| uterus | 100% | 24653.35 | 170 / 170 | 97% | 190.61 | 446 / 459 |
| lung | 100% | 24026.48 | 577 / 578 | 96% | 144.80 | 1111 / 1155 |
| esophagus | 100% | 21856.30 | 1445 / 1445 | 95% | 97.67 | 173 / 183 |
| bladder | 100% | 21449.48 | 21 / 21 | 94% | 189.30 | 473 / 504 |
| stomach | 97% | 9720.14 | 350 / 359 | 95% | 163.87 | 272 / 286 |
| breast | 100% | 16382.78 | 459 / 459 | 92% | 169.64 | 1033 / 1118 |
| skin | 99% | 13244.00 | 1799 / 1809 | 89% | 235.51 | 419 / 472 |
| ovary | 100% | 48875.94 | 180 / 180 | 75% | 83.60 | 323 / 430 |
| thymus | 98% | 7773.44 | 637 / 653 | 74% | 90.59 | 448 / 605 |
| brain | 88% | 6803.81 | 2312 / 2642 | 78% | 55.81 | 548 / 705 |
| kidney | 84% | 5460.10 | 75 / 89 | 78% | 157.24 | 707 / 901 |
| pancreas | 10% | 421.51 | 34 / 328 | 98% | 349.90 | 175 / 178 |
| ureter | 0% | 0 | 0 / 0 | 100% | 45.89 | 1 / 1 |
| blood vessel | 100% | 13952.79 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 13582.77 | 1200 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 156.79 | 44 / 45 |
| eye | 0% | 0 | 0 / 0 | 88% | 157.54 | 70 / 80 |
| heart | 87% | 5841.16 | 749 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 72% | 50.80 | 21 / 29 |
| adrenal gland | 21% | 868.35 | 55 / 258 | 26% | 19.51 | 59 / 230 |
| spleen | 29% | 1255.92 | 71 / 241 | 0% | 0 | 0 / 0 |
| liver | 0% | 12.88 | 1 / 226 | 9% | 10.27 | 38 / 406 |
| muscle | 7% | 262.59 | 54 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0048812 | Biological process | neuron projection morphogenesis |
| GO_0007165 | Biological process | signal transduction |
| GO_0035582 | Biological process | sequestering of BMP in extracellular matrix |
| GO_0045666 | Biological process | positive regulation of neuron differentiation |
| GO_0090027 | Biological process | negative regulation of monocyte chemotaxis |
| GO_0030514 | Biological process | negative regulation of BMP signaling pathway |
| GO_0007399 | Biological process | nervous system development |
| GO_0048263 | Biological process | determination of dorsal identity |
| GO_0038098 | Biological process | sequestering of BMP from receptor via BMP binding |
| GO_0009887 | Biological process | animal organ morphogenesis |
| GO_0005615 | Cellular component | extracellular space |
| GO_0016015 | Molecular function | morphogen activity |
| GO_0036122 | Molecular function | BMP binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0048018 | Molecular function | receptor ligand activity |
| Gene name | NBL1 |
| Protein name | NBL1, DAN family BMP antagonist Neuroblastoma suppressor of tumorigenicity 1 Neuroblastoma suppressor of tumorigenicity 1 (DAN domain family member 1) (Protein N03) (Zinc finger protein DAN) |
| Synonyms | DAN DAND1 |
| Description | FUNCTION: Possible candidate as a tumor suppressor gene of neuroblastoma. May play an important role in preventing cells from entering the final stage (G1/S) of the transformation process. |
| Accessions | ENST00000615215.4 ENST00000451758.5 ENST00000622566.4 [P41271-1] ENST00000548815.2 [P41271-1] A3KFI5 ENST00000439664.5 A3KFI2 ENST00000428975.5 ENST00000602662.1 [P41271-1] A0A087WTY6 ENST00000289749.6 [P41271-2] A3KFI3 P41271 A3KFI1 ENST00000425400.5 ENST00000618761.4 [P41271-1] ENST00000621723.4 [P41271-1] ENST00000375136.8 [P41271-1] ENST00000439278.5 A3KFI4 E5RFZ1 ENST00000427894.5 |